0.0.1 / December 4, 2014
(5.0/5) (2)

Description

CV-risk and prevention – Theprogrampurpose
The interactive application "CV-Risk and prevention" wasdevelopedfor clinical practice to calculate cardiovascular risksforindividual patients and typical patient profiles. Thisriskassessment may assist in prevention of cardiovasculardiseases.Individual risks can be identified, controlled and reducedbymedication and/or lifestyle changes.
The probability to develop a CVD is most frequently the resultofmultiple interacting risk factors. These factors were analyzedtodetermine the 10-year risk of coronary heart disease(FraminghamScore), the 10-year risk of fatal cardiovascular disease(SCOREChart), personal risks, and the patient’s position in theprocessesof the cardiovascular continuum. Because diabetesinfluences thecardiovascular risk, either the determination of thediabetes riskby the DRS-score or the diabetes associated vascularrisk IRIS IIscore were integrated.

How to use it:
After choosing a predefined patient profile, the riskcalculatorscreen appears. Individual patient parameters can beindividuallymodified such as gender, age, BP, lab values,etc.
On the right side calculated results of the risk evaluation,thescores and a list of individual lifestyle risks and measuresaredisplayed. A PDF- report for the patient with importantriskfactors, targets, and advices for lifestyle changes canbegenerated.
In the personalized CV risk continuum all risks andthepatient&apo;s position on the way to develop of renal orCVdisease, are highlighted.

The section "Micardis evidence based benefit" presentsthestudy-based risk minimization by MICARDIS therapy and offersadirect access to the study in the STAR Trial database "EvidenceinCardio & Vascular Protection".

The QUICK GUIDE provides a more detailed description oftheprogram.

App Information CV risk and prevention

  • App Name
    CV risk and prevention
  • Package Name
    com.academy.cvrisk
  • Updated
    December 4, 2014
  • File Size
    Undefined
  • Requires Android
    Android 2.3.3 and up
  • Version
    0.0.1
  • Developer
    Academy GmbH & Co. KG
  • Installs
    500 - 1,000
  • Price
    Free
  • Category
    Medical
  • Developer
  • Google Play Link

Academy GmbH & Co. KG Show More...

AsthmaLaVista 1.02 APK
AsthmaLaVista ist die pfiffige App, alleInfosrund um Dein Asthma immer dabei zu habenDu bekommst ein interaktives Tagebuch zum EintragenDeinerPeak-Flow-Werte, Du kannst Dir den Kurvenverlauf alsgraphischeAuswertung anschauen, es gibt tagesaktuellePollenflugdaten und Dukannst Termine und Medikamente verwalten. Dukannst auf einer Kartesehen, an welchem Ort Du Deine Einträgegemacht hast und alle Datenauch für Dich oder Deinen Arztexportieren.Asthmatagebuch:• Protokollierung der Peak-Flow-Messung (inkl.Best-Wert-Erfassung),aufgetretener Symptome und Abweichungen vomBehandlungsplan, freieNotizfunktion• Tages- und Monatsansicht mit Kennzeichnung der Tagemitabweichenden Werten• Automatische grafische Darstellung der Peak-Flow-Werte inkl.50-und 80% Bestwertkurven bei Rotation des Gerätes• Ampelfunktion zur Schnellübersichtverbesserter/verschlechterterPeak-Flow-Werte• Erfassung Arbeitstag ja/nein• Automatische Aufzeichnung der GPS-Position und DarstellungderOrte der Symptomerfassung.• PDF-Export der Tagebucheinträge per E-Mail• Selbsttest zur AsthmatherapieErinnerungsfunktion:• Tages- und Monatsansicht• Freie Anlage beliebiger Erinnerungen, auchAsthma-unabhängig• Erinnerungen auch einzeln deaktivierbar• Erinnerung zur Peak-Flow-Messung• Erinnerung zur MedikamenteneinnahmeAktueller saisonaler Pollenflug (nur mit Online-Verbindung,währendder Pollenflugsaison):• Anzeige des tagesaktuellen Pollenflugs• Bei GPS-Empfang automatische Darstellung des Pollenflugsimaktuellen Bundesland• Frei wählbare Anzeige aller BundesländerEigenes Profil:• Anlage des persönlichen Profils, freiwillige Einträge• Peak-Flow-Bestwert, Allergien, Berufsgruppe (Allergene)undweitere pers. Daten• Erfassung des Medikamentenplans mit Erinnerungsfunktionbeigeringer Medikamentenrestmenge• Erfassung des Sport-/ AktivitätsplansVoraussetzungen / Hinweise:• Daten werden nicht extern gespeichert, eigene Datensicherungggf.erforderlichAsthmaLaVista istheclever app, all information about your asthma to alwayscarryYou get an interactive diary for entering your peak flow values,youcan you the curve shown as graphical analysis, there areupdateddaily pollen data and you can manage appointments andmedications.You can see on a map on where you made your entriesand export allthe data for you too, or your doctor.Asthma diary:• logging of peak flow measurement (includingbest-valueacquisition), symptoms occurred and deviations from thetreatmentplan, free memo• Daily and monthly view with identification of days withdifferentvalues• Automatic graph of peak flow values ​​including 50 - and80%Bestwertkurven during rotation of the device• Traffic light function for quick reference improved /deterioratedpeak flow values• Acquisition working yes / no• Automatic recording of GPS position and representation ofthelocations of the symptom detection.• PDF export of diary entries by e-mail• Self-test for asthma therapyReminder:• Day and month view• Free installation of any memories, and asthma-independent• individually memories can be deactivated• Reminder to peak flow measurement• Reminders to take medicationCurrent seasonal pollen (only with online connection, duringthepollen season):• Display of the daily pollen count• If GPS reception automatic presentation of pollen in thecurrentstate• Selectable display all statesOwn profile:• Plant a personal profile, voluntary entries• peak flow optimum, allergies, occupational group (allergens)andmore pers data• Acquisition of the drug plan with reminders at lowdrugresidue• Acquisition of the sport / activity planRequirements / Notes:• Data is not stored externally own backup if needed
Hypertension guideline check 0.0.1 APK
HGCheck – The program purposeThe interactive application HGCheck (Hypertension GuidelineCheck)was developed for clinical practice in supporting treatmentofhypertensive patients according to the currentguidelinerecommendations. It is based on the 2013 ESH/ESCGuidelines for themanagement of arterial hypertension.The antihypertensive treatment initiation and intensity foranindividual patient depends - in addition to the grade ofarterialhypertension - on further cardiovascular risk factorsdemonstratedin the program. By specifying the conditions ofpatients fillinginformation and individual recommendations areprovided.How to use it:After entering patient data such as gender, age and bloodpressure,followed by risk factors and possible diseases, theprogramprovides it results in a stratification table specificationandevaluation of the overall risk and the guideline recommendationsofantihypertensive treatment. Behind the highlighted riskbutton(“more...”) to read more details.Common recommendations of treatment strategies and drugcombinationsare given and can be detailed.To learn about especially preferred or contraindicated drugsforspecific patient, further conditions can be checked behindtherelated label. A resulting drug-table helps to assess the bestdrugchoice.Please consider: The guidelines give recommendations of riskandtreatment just for the initiation of antihypertensive therapy.Ifthis patient has already been treated the program providessomehints relating to the current blood pressure under therapyandindicates contraindications and preferred drugs.Handouts for patients can be generated (PDF) and printed.If you want to give a handout to your patient, clicktheReport-Button. The generated document includes the mostimportantdata, the cardiovascular risk and recommendations oflifestylemeasures.The integrated QUICK GUIDE is for a more detailed descriptionofthe application.
Evidence in CV Protection 0.0.1 APK
Evidence in Cardio & Vascular Protection –The program purposeOver the past few years, evidence-based medicine has becomeincreasingly important in medical decision-making. Clinical trialsremain the most reliable source of medical data. Therefore, it isnecessary to achieve a rapid overview on study data on specificpatient profiles and indications to compare their backgrounds,substances used, patient populations and results.The “Evidence in Cardio & Vascular Protection” trial databaseoffers a uniform display of study criteria with quick and directaccess to the information needed. The medical content is providedin an extracted form, summarizing the key essentials of thepublication. Wherever possible, large blocks of solid text areavoided and the presentation is kept down to key words with cleargraphics yet without omitting essential statements and importantvalues.
CV risk and prevention 0.0.1 APK
CV-risk and prevention – TheprogrampurposeThe interactive application "CV-Risk and prevention" wasdevelopedfor clinical practice to calculate cardiovascular risksforindividual patients and typical patient profiles. Thisriskassessment may assist in prevention of cardiovasculardiseases.Individual risks can be identified, controlled and reducedbymedication and/or lifestyle changes.The probability to develop a CVD is most frequently the resultofmultiple interacting risk factors. These factors were analyzedtodetermine the 10-year risk of coronary heart disease(FraminghamScore), the 10-year risk of fatal cardiovascular disease(SCOREChart), personal risks, and the patient’s position in theprocessesof the cardiovascular continuum. Because diabetesinfluences thecardiovascular risk, either the determination of thediabetes riskby the DRS-score or the diabetes associated vascularrisk IRIS IIscore were integrated.How to use it:After choosing a predefined patient profile, the riskcalculatorscreen appears. Individual patient parameters can beindividuallymodified such as gender, age, BP, lab values,etc.On the right side calculated results of the risk evaluation,thescores and a list of individual lifestyle risks and measuresaredisplayed. A PDF- report for the patient with importantriskfactors, targets, and advices for lifestyle changes canbegenerated.In the personalized CV risk continuum all risks andthepatient&apo;s position on the way to develop of renal orCVdisease, are highlighted.The section "Micardis evidence based benefit" presentsthestudy-based risk minimization by MICARDIS therapy and offersadirect access to the study in the STAR Trial database "EvidenceinCardio & Vascular Protection".The QUICK GUIDE provides a more detailed description oftheprogram.